Astrana Health (ASTH) Receivables (2011 - 2026)

Astrana Health has disclosed Receivables across 16 years of filings, most recently posting $495.4 million for Q1 2026.

• Receivables for Q1 2026 came in at $495.4 million, up 93.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $495.4 million (up 93.52% YoY), and the FY2025 annual result was $400.8 million, up 31.22% from the prior year.
• Receivables came in at $495.4 million for Q1 2026 at Astrana Health, up from $400.8 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $495.4 million in Q1 2026 to a low of $14.3 million in Q1 2022.
• The 5-year median for Receivables is $105.6 million (2022), against an average of $180.7 million.
• Across the five-year window, Receivables slumped 82.88% in 2022 and surged 957.56% in 2023, its largest moves.
• Astrana Health's Receivables stood at $74.0 million in 2022, then declined by 18.88% to $60.0 million in 2023, then jumped by 408.79% to $305.5 million in 2024, then surged by 31.22% to $400.8 million in 2025, then grew by 23.59% to $495.4 million in 2026.
• The last three Receivables figures came in at $495.4 million (Q1 2026), $400.8 million (Q4 2025), and $391.1 million (Q3 2025), per Business Quant data.